Ignite Creation Date:
2025-12-25 @ 1:38 AM
Ignite Modification Date:
2025-12-31 @ 10:25 AM
Study NCT ID:
NCT03294694
Status:
TERMINATED
Last Update Posted:
2025-05-31
First Post:
2017-09-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-11-08
Start Date Type:
ACTUAL
Primary Completion Date:
2020-10-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-10-14
Completion Date Type:
ACTUAL
First Submit Date:
2017-09-19
First Submit QC Date:
None
Study First Post Date:
2017-09-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-27
Last Update Post Date:
2025-05-31
Last Update Post Date Type:
ACTUAL